6505--Budesonide/Formoterol INH
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), through its National Acquisition Center, intends to issue a Request for Proposal (RFP) for an unrestricted procurement of Budesonide/Formoterol INH. This contract will supply the VA (including Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The VA plans to award one contract to a responsible offeror capable of providing an uninterrupted source of supply. The solicitation, #36E79726R0013, is expected to be issued on or about March 30, 2026, with a tentative closing date of April 13, 2026.
Scope of Work
The primary requirement is the supply of Budesonide/Formoterol INH. Offerors must specify the exact drug name as it appears on the label and ensure the drug has a unique National Drug Code (NDC) number specific to the offeror. Estimated annual requirements include:
- BUDESONIDE 160MCG/FORMOTEROL FUM 4.5MCG/SPRAY INHL,ORAL,10.2GM: 722,021 canisters
- BUDESONIDE 80MCG/FORMOTEROL FUM 4.5MCG/SPRAY INHL,ORAL,10.2GM: 220,295 canisters Distribution of contracted items will occur through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
Contract & Timeline
- Opportunity Type: Pre-solicitation (RFP to follow)
- Contract Type: One contract award (type not specified, but will be for supply)
- Duration: One base year plus four pre-priced one-year option periods.
- Set-Aside: Unrestricted
- Solicitation Number: 36E79726R0013
- Anticipated Solicitation Release: On or about March 30, 2026
- Tentative Closing Date: April 13, 2026 (2:30 PM Central Time, Chicago, USA)
- Published Date: March 24, 2026
Eligibility & Submission
This is an unrestricted procurement, and all responsible sources are invited to submit an offer once the solicitation is released. The solicitation will be issued electronically in commercial item format in accordance with FAR Part 12. Offerors should continuously monitor SAM.gov for the official solicitation, amendments, and other documents. No paper copies will be available.
Additional Notes
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
- Product Service Code: 6505 (Drugs And Biologicals)
- Contracting Office: NAC PHARMACEUTICALS (36E797)
- Point of Contact: Kenneth Lay, Contract Specialist, Kenneth.Lay@va.gov, (708) 786-4879.